SLDB CIK: 1707502

Solid Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
223
FY22:
220
FY23:
130
FY24:
157
FY25:
205
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.77
FY22:
40.6
FY23:
35.2
FY24:
31.4
FY25:
27.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
232
FY22:
260
FY23:
165
FY24:
189
FY25:
233

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
23.6
FY22:
22.5
FY23:
14.5
FY24:
30.3
FY25:
33.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.57
FY22:
26.1
FY23:
23.9
FY24:
21.2
FY25:
19.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
208
FY22:
212
FY23:
126
FY24:
137
FY25:
180
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
232
FY22:
260
FY23:
165
FY24:
189
FY25:
233

All amounts in millions USD Data source:SEC EDGAR